Forma
Formatech accelerates drug development with unique solutions, specializing in formulation, lyophilization, and aseptic manufacturing.
Founded
1993Formatech accelerates drug development with unique solutions, specializing in formulation, lyophilization, and aseptic manufacturing.
Formatech, founded in 1993, is dedicated to accelerating drug development by providing innovative solutions to product development and manufacturing challenges. The company's core mission is to expedite the creation of new drugs at the speed of science. Formatech offers a range of services including preformulation and formulation development for various dosage forms, lyophilization development, cell culture and fermentation process development, purification and downstream process development, and aseptic fill and finish of both liquid and lyophilized products. Their market focus is on pharmaceutical companies seeking efficient and reliable drug development processes.
Notable figures affiliated with Formatech include industry experts in pharmaceutical sciences and bioprocessing. The company has garnered attention from key investors in the biotech sector, contributing to its growth and innovation. Formatech's key achievements include successful partnerships with leading pharmaceutical firms and the development of numerous drug formulations that have advanced to clinical trials. The overall impact of Formatech lies in its ability to streamline drug development, thereby accelerating the availability of new therapies to patients in need.
Companies similar to Forma include AustinPx, FormAhead, Vaxform and US Specialty Formulations.
Forma was founded in 1993.
Forma's headquarters is located in San Francisco, CA, US.
Forma's most recent funding round was for $7M (USD) in January 2020.
As of Jan 31, 2020, Forma has raised a total of $7M (USD).
Forma has 30 employees as of Feb 4, 2024.
Vaxform
vaxform.com
